Zydus Cadila may apply for EUA of ZyCoV-D next week Press Trust of India Jun 19, 2021 If approved, it will be the world's first DNA vaccine against coronavirus and the fourth to become available in the country
Cadila Healthcare to make around 30 million doses of COVID-19 vaccine a month: Managing Director Reuters May 24, 2021 The company will use both in-house capacity as well as third-party manufacturers to boost production
Cadila Healthcare initiates production of ZyCoV-D Reuters Apr 23, 2021 It will seek emergency use authorisation in May or June, informed the company's MD
Covishield to dominate overall COVID-19 vaccination drive in India: GlobalData EP News Bureau Jan 15, 2021 SII has taken the lead in supplying orders for the Indian government through 11 million doses ordered of Covishield versus 5.5…
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D EP News Bureau Jan 3, 2021 The company will now be initiating Phase III clinical trial in around 30,000 volunteers
Zydus seeks approval for Phase III clinical trials of ZyCoV-D, submits Phase I/II clinical trial… EP News Bureau Dec 25, 2020 ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials, informs company
COVID-19 expedites India’s focus on innovation within pharma: GlobalData EP News Bureau Dec 15, 2020 According to the Global Innovation Index, India has moved up four places to 48 in the overall ranking across sectors in 2020
Modi visits key vaccine facilities as COVID-19 case load surges Reuters Nov 28, 2020 The Prime Minister Narendra Modi toured three of the nation’s leading vaccine development and manufacturing sites on Saturday as…
Zydus Cadila launches remdesivir at Rs 2800 per 100 mg vial EP News Bureau Aug 13, 2020 To be sold under brand name Remdac, the API for the drug has been developed and manufactured at the company’s API manufacturing…
Success of indigenous COVID-19 vaccines will make access easy and affordable in India: GlobalData EP News Bureau Aug 12, 2020 There are 13 Indian organisations working on COVID-19 vaccine development